These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10784377)

  • 1. Correlation of low-density lipoprotein modification by myeloperoxidase with hypochlorous acid formation.
    Jerlich A; Horakova L; Fabjan JS; Giessauf A; Jürgens G; Schaur RJ
    Int J Clin Lab Res; 1999; 29(4):155-61. PubMed ID: 10784377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols.
    Hazen SL; Hsu FF; Duffin K; Heinecke JW
    J Biol Chem; 1996 Sep; 271(38):23080-8. PubMed ID: 8798498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of chlorination of monochlorodimedone by myeloperoxidase.
    Jerlich A; Tschabuschnig S; Fabjan JS; Schaur RJ
    Int J Clin Lab Res; 2000; 30(1):33-7. PubMed ID: 10984130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.
    Heinecke JW
    Biofactors; 1997; 6(2):145-55. PubMed ID: 9259996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
    Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.
    Malle E; Marsche G; Arnhold J; Davies MJ
    Biochim Biophys Acta; 2006 Apr; 1761(4):392-415. PubMed ID: 16698314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved method for the sensitive monitoring of low density lipoprotein modification by myeloperoxidase.
    Jerlich A; Hammel M; Horakova L; Schaur RJ
    Redox Rep; 2001; 6(4):257-64. PubMed ID: 11642717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
    Pattison DI; Davies MJ; Hawkins CL
    Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase.
    Kettle AJ; Gedye CA; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):2003-10. PubMed ID: 8390258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
    Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
    Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
    Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
    Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl.
    Jerlich A; Hammel M; Nigon F; Chapman MJ; Schaur RJ
    Eur J Biochem; 2000 Jul; 267(13):4137-43. PubMed ID: 10866816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein.
    Byun J; Mueller DM; Fabjan JS; Heinecke JW
    FEBS Lett; 1999 Jul; 455(3):243-6. PubMed ID: 10437781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
    Hazen SL; Heinecke JW
    J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction of myeloperoxidase with its product HOCl.
    Floris R; Wever R
    Eur J Biochem; 1992 Jul; 207(2):697-702. PubMed ID: 1321719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
    Sutherland WH; de Jong SA; Walker RJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines.
    Panasenko OM; Spalteholz H; Schiller J; Arnhold J
    Free Radic Biol Med; 2003 Mar; 34(5):553-62. PubMed ID: 12614844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
    Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
    Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
    Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
    Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of myeloperoxidase-dependent chlorination of monochlorodimedon.
    Kettle AJ; Winterbourn CC
    Biochim Biophys Acta; 1988 Nov; 957(2):185-91. PubMed ID: 2847800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.